baber/WOPTO huggingface dataset:
Patent CA-2506440-A1 (CA)
Title: Magnetized frets for a stringed musical instrument
Inventor: THOEN LORNE
IPC: G10D3/22
Filed: 2005-05-06
Abstract: The present invention is concerned with providing a fret for a stringed musical instrument having strings containing ferromagnetic material, wherein the fret is arranged to be magnetic. Having a downward magnetic force exerted on the strings by a fret ensures full and consistent contact between a string and the fret when the string is pressed down against the fret. The invention has three embodiments that describe different ways of providing magnetism to the fret. In a first embodiment the fret is comprised of magnetic material. In a second embodiment a magnet is coupled to the fret to supply magnetic properties to the fret. In a third embodiment an electromagnetic coil is wrapped around a portion of the fret in order to induce magnetism.
Patent CA-2508064-A1 (CA)
Title: Trailer hitch device
Inventor: GURTLER WENDELL A
IPC: B60D1/52
Filed: 2005-05-20
Abstract: The present invention is directed toward a trailer hitch assembly hat includes a pair of brackets secured to a vehicle frame in parallel spaced relation aid a pair of arms secured to the brackets. A torsion bar is provided that extends between and is secured to the arms. Additionally, a receiver is provided that extends outwardly from the torsion bar and has an opening for receiving a draw bar far a hitch.      In another embodiment, the trailer hitch assembly is adapted for use with a conventional trailer hitch mounted to a vehicle and includes a draw bar adapted to be inserted within the receiver of the conventional trailer hitch.
Patent CA-2508750-A1 (CA)
Inventor: PESSAYRE STEPHANIE
IPC: F24C15/00
Filed: 2003-11-20
Abstract: A heating device has metal walls which are at least partly covered with a self-cleaning coating having an outer layer in contact with ambient air, made of at least one oxidizing catalyst chosen from among the platinum oxides, and at least one inner layer (3) between the metallic support and the outer layer made of an oxidation catalyst chosen from the oxides of Group 1b transition elements. The catalyst in the outer layer is an oxide of palladium or platinum or a mixture of these. The catalyst in the inner layer is an oxide of copper, silver or a mixture of these. In particular, the outer layer is a palladium oxide and the inner layer a silver oxide, or the outer layer is a mixture of palladium oxide and silver oxide. The thickness of the outer layer, measured using the RBS method, is 10-500 nm, preferably 20-120 nm. The thickness of the inner layer, measured using the RBS method, is 20-50 nm. An additional intermediate layer (5) can be placed between the metallic support and the inner layer, forming a catalytically inert support made of aluminum, enamel, polytetrafluoroethylene or a mixture of these. The intermediate layer is made of enamel. The device is in the shape of a cooking device with walls which are prone to be in contact with organic dirt and the coating covers these walls. An Independent claim is included for coating the metallic support of a heating device with a self-cleaning coating as described above, by (i) heating the surface of the metallic support to 400degreesC, (ii) placing it in contact under infrared at 400-600degreesC for several seconds, (iii) spraying a solution of a catalytic precursor to form the inner layer, (iv) reheating the surface in an oven to ca. 400degreesC, (v) placing it again under infrared at 400-600degreesC for several seconds, spraying a solution of a catalytic precursor to form the outer layer, and (vii) reheat the metallic support with infrared for several minutes.
Patent CA-2509396-A1 (CA)
Title: Compositions adoucissantes concentrees contenant des modificateurs de rheologie assurant le maintien de la stabilite et de la fluidite apres une dilution
Inventor: SALESSES ISABELLE
IPC: C11D3/00
Filed: 2003-12-12
Abstract: L'invention concerne une composition adoucissante aqueuse concentrée présentant une viscosité comprise entre environ 3000 cps et environ 15000 cps, de préférence entre 4000 et 15000 cps, cette composition pouvant être diluée avec de l'eau selon un rapport de 4:1 en poids entre l'eau et la composition adoucissante concentrée avant une utilisation de sorte que la composition adoucissante diluée résultante soit physiquement stable et présente une viscosité moyenne comprise entre environ 90 cps et environ 300 cps.
Patent CA-2510216-A1 (CA)
Title: Structural wall framework
Inventor: TADICH JOHN
IPC: E04B1/26
Filed: 2005-06-20
Abstract: A building framework is disclosed which comprises studs 12 and 14. The studs 12 and 14 are coupled together by separate bracing elements 16 and 17.     The studs 12 and 14 and bracing elements 16 and 17 form a bracing unit 10. The bracing unit 10 is provided between a top plate 51 and bottom plate 52.  The bracing elements 16 and 17 extend substantially all of the way from the top plate 51 to the bottom plate 52. The bracing unit may have more studs, such as bracing unit 20 comprising three studs 22, 24, and 26.
Patent CA-2511212-A1 (CA)
Title: Surface conditioner for powder coating systems
Inventor: WILSON NEIL R
IPC: C09D7/00
Filed: 2005-06-30
Abstract: The present invention relates to methods for conditioning a surface before application of powder coating, methods for improving powder coating transfer to a surface, methods for reducing defects on powder painted surfaces, methods for providing homogenous surface charge on a surface, methods for increasing adhesion of powder paint to a surface, and surface conditioners for use in such methods.
Patent CA-2513104-A1 (CA)
Inventor: STRATEN EIVIND PER THOR
IPC: A61P35/00
Filed: 2004-01-30
Abstract: MHC Class I-restricted peptides derived from the tumor associated antigen, survivin, which peptides are capable of binding to Class I HLA molecules at a high affinity, capable of eliciting INF-.gamma.-producing cells in a PBL  population of a cancer patient and capable of in situ detection of cytotoxic T  cells in a tumor tissue, therapeutic and diagnostic composition comprising the peptide and uses thereof.
Patent CA-2518076-A1 (CA)
Inventor: OZAWA YOICHI
IPC: A61K45/06
Filed: 2004-04-30
Abstract: The present invention provides a medicinal composition having an excellent antitumor activity. That is, it provides a medicinal composition comprising N-(3-chloro-1H-indol-7-yl)-4-sulfamoylbenzenesulfonamide or a salt thereof, combined with at least one substance selected from (1) carboplatin; (2) oxaliplatin; (3) capecitabine; and (4) a salt of the above-mentioned (1) to (3).
Patent CA-2522075-A1 (CA)
Inventor: MIZOHATA SEIJI
IPC: A41B17/00
Filed: 2004-06-17
Abstract: A woven or knitted fabric containing two yarns being different from each other in the self-elongation by absorption of water, which is defined in the specification, characterized in that the ratio A/B of an average length (A) of a yarn (1) exhibiting a higher self-elongation to an average length (B) of a yarn (2) exhibiting a self-elongation lower than that of the above yarn (1) is 0.9 or less and it exhibits enhanced air permeability when it has a higher moisture content.
Patent CA-2526941-A1 (CA)
Inventor: GONSALVEZ BRIAN
IPC: H04M11/06
Filed: 2004-05-21
Abstract: An access provider technician can inquire, from a remote location, a status of an upper-layer communication indicator. For example, a technician, after receiving a trouble call from an end-user, can ask the end-user the visual status of the upper-layer communication indicator. Next, the technician can enter the status into data storage, for example, an electronic job ticket. A  first set of actions is performed if the status indicates valid communication.  A second set of actions is performed if the status indicates invalid communication. The upper-layer communication indicator indicates a high layer communication status, for example, layer 3 of the OSI model, such as a Point-to-Point Protocol over Ethernet (PPPoE) authentication status.
Patent CA-2527123-A1 (CA)
Inventor: CLARK KIRTLAND P
IPC: C09K21/14
Filed: 2004-06-18
Abstract: A foam concentrate provides a fire-fighting composition when mixed with water so that the fire-fighting composition does not form a stable seal on cyclohexane and meets UL 162, Class B performance criteria for at least one of AFFF agents and fluoroprotein (FP) agents without requiring organic fluorine.  The concentrate is formed from water and a high molecular weight acidic polymer (HMWAP) and a coordinating salt.
Patent CA-2529296-A1 (CA)
Title: Actuator for a pressurized material dispenser
Inventor: MILLER ALLEN D
IPC: B65D83/16
Filed: 2004-06-16
Abstract: An actuator orifice and an actuator for enhancing or creating a foam from a pressurized material dispenser. The actuator (10) includes a skirt (14) attached to the dispenser and a trigger (20) movably mounted to the skirt. The trigger includes a flow conduit with a socket for receiving a valve stem. The socket exerts pressure on the stem to release contents of the dispenser. The trigger includes a hollow flow diverter (60) located within the chamber (40).  The flow diverter has a side wall and an end wall extending inwardly from the flow diverter side wall. The flow diverter side wall in turn has slots that provide fluid paths between the flow conduit and a surrounding chamber. The chamber side wall has recesses. Each slot laterally directs contents of the dispenser into at least one of the recesses in the chamber side wall when the valve is activated by the trigger.
Patent CA-2529447-A1 (CA)
Inventor: KITAOKA KENICHI
IPC: A61K9/28
Filed: 2004-06-24
Abstract: The present invention relates to a fluvastatin-containing tablet, particularly a fluvastatincontaining tablet which has excellent disintegrating property and good bioavailability. The fluvastatin-containing tablet is characterized in comprising carmellose calcium as a disintergrating agent.
Patent CA-2532220-A1 (CA)
Title: Measurement of a polynucleotide amplification reaction
Inventor: DENSHAM DANIEL HENRY
IPC: C12Q1/68
Filed: 2004-07-15
Abstract: A quantitative measurement of the progress of a polynucleotide amplification reaction can be made by: (i) carrying out a reaction for the amplification of a target polynucleotide; (ii) either during or after the amplification reaction contacting the amplified product with a molecule that binds to or interacts with a polynucleotide, the molecule being located in a spatially defined position or being determined via a non-linear or non-fluorescent technique; and (iii) detecting the interaction between the amplified product and the molecule by measuring changes in radiation.
Patent CA-2533503-A1 (CA)
Title: Antibodies to the fbsa protein of streptococcus agalactiae and their use in treating or preventing infections
Inventor: SPEZIALE PIETRO
IPC: G01N33/554
Filed: 2004-07-23
Abstract: Monoclonal and polyclonal antibodies are provided which can bind to the FbsA  protein of Streptococcus agalactiae (GBS) and which can be used to prevent adherence of the bacteria to host cells and thus be useful in the treatment and protection against infection from S. agalactiae. The antibodies of the invention can also be raised against the fibrinogen binding domain of FbsA or the repeat region therein, and in addition to preventing bacterial adherence, the antibodies to FbsA are advantageous in that they can be used to prevent platelet aggregation and thrombus formation.
Patent CA-2537449-A1 (CA)
Inventor: BEALE DEAN ALASTAIR ROBERT
IPC: G08C17/02
Filed: 2004-09-02
Abstract: A sensor module for use in a sensor network is described. The sensor module carries one or more sensor element (8), such as microphones or imaging devices, for detecting events in use. The sensor module has a locator for determining its location and preferably an orientation sensor for determining it location and a transceiver for communicating with other modules in the network or with a base station. The module also has a processor which is adapted such that, in use, the module communicates with other sensor modules and determines whether to operate in a sensing mode to detect events or a controlling mode. In this way a self organising adaptive network is provided.  The invention is particularly useful for rapid area deployment resulting in random placement such as by gun launch or air drop as once all the modules are deployed the network will work out which modules should act as sensor nodes and which should act as controlling nodes so as to maximise network efficiency.
Patent CA-2537711-A1 (CA)
Title: Universal positioning block assembly
Inventor: COUTURE PIERRE
IPC: A61B34/10
Filed: 2006-02-27
Abstract: A universal positioning block for use in bone surgery, permitting up to six degrees-of-freedom movement relative to a bone element to which it is fixed.  The positioning block comprises a main block element that is releasably engageable to the bone element such that the main block element is rotatable in a flexion-extension rotation plane and translatable along a medio-lateral axis relative to the bone element. A slider element is engaged with the main block element such that it is translatable along an antero-posterior axis and rotatable in a varus-valgus rotation plane relative thereto and a holder element is engaged with the slider element such that it is translatable relative thereto along a proximal-distal axis and may also further be rotatable in a medio-lateral rotation plane, the holder element being habilitated for engaging a surgical tool guide element.
Patent CA-2537997-A1 (CA)
Inventor: LIEBMANN-VINSON ANDREA
IPC: C12N11/16
Filed: 2004-08-26
Abstract: The current invention relates to methods of producing a surface with enhanced cell-formed surface such that at least one intermediate adhesive properties comprising treating a pre reactive group is exposed on the surface. The exposed intermediate reactive group is then reacted to create a self-assembled monolayer, comprising at least one reactive group. The self~-assembled monolayer is created non-mechanically. The reactive group is then coupled to at least one cell-adhesive molecule. The current invention also relates to cell culture devices comprising at least one oxygen-sensing compound and a cell-adhesive molecule.
Patent CA-2539506-A1 (CA)
Title: Procede de commande d'un dispositif photosensible
Inventor: COUDER DAVID
IPC: H04N5/357
Filed: 2004-10-13
Abstract: La présente invention concerne un procédé de commande d'un dispositif photosensible (1, l') comprenant une matrice (2, 20) de points photosensibles (Pl à P9) repartis aux intersections de lignes (SY1 à SY3) et de colonnes (X1 à X3) de la matrice (2, 20). L'invention concerne plus particulièrement (mais non exclusivement) la commande de tels dispositifs utilisés pour la détection d'images radiologiques. Le procédé consiste à soumettre la matrice (2, 20) à  un cycle d'image comprenant une phase d'initialisation précédent une phase de prise d'image. Les lignes de la matrice (2, 20) sont réparties en plusieurs groupes, et durant la phase d'initialisation, le procédé consiste à remettre à  zéro simultanément toutes les lignes d'un même groupe et à remettre à zéro successivement chaque groupe de lignes.
Patent CA-2540706-A1 (CA)
Inventor: SAKAI MASATO
IPC: A01K67/027
Filed: 2004-09-27
Abstract: A royal jelly peptide which has a function as a queen bee~s attraction cofactor and can enhance the biological defense system of an animal (an immunopotentiating effect); and a composition containing the same.
Patent CA-2540865-A1 (CA)
Inventor: KIM SO-HYUN
IPC: H04W36/26
Filed: 2004-11-08
Abstract: L'invention concerne un système et un procédé permettant de commander un transfert intercellulaire d'un poste d'abonné mobile dans un système de communication à accès sans fil de bande large. Lorsqu'une station de base de service détermine qu'il faut effectuer un transfert intercellulaire du poste d'abonné mobile, des stations de base voisines, vers lesquelles le poste d'abonné mobile peut être transféré, sont déterminées en fonction du niveau de qualité de service qui est actuellement fourni au poste d'abonné mobile. Un signal de demande de transfert intercellulaire contenant des informations liées à la station de base voisine déterminée est transmis au poste d'abonné mobile. Cette station de base de service permet de recevoir du poste d'abonné mobile, en réponse à la demande de transfert intercellulaire, des informations concernant une station de base voisine, vers laquelle le poste d'abonné mobile a été transféré, et elle permet d'informer la station de base voisine que le poste d'abonné mobile a été transféré vers la station de base voisine.
Patent CA-2541503-A1 (CA)
Inventor: NAGEL PHILLIPE
IPC: F28B1/06
Filed: 2006-03-31
Abstract: An air-cooled condenser (1) for the condensation of steam by means of air is described, said air-cooled condenser comprising a steam supply line (2), at least one upwardly directed pipe bundle (6), to which the steam to be condensed can be supplied, a condensate drain for the drainage of condensed steam and a fan (11) for the air transport to the pipe bundle (6).  The pipe bundle (6) is arranged below the fan (11) in a sidewall (18) of the air-cooled condenser (1). Several pipe bundles (6) are thereby arranged in such a way that they form a jacket (13) in the form of a polygon extending in the plumb line, wherein said jacket is closed such that it forms an enclosure on all sides.
Patent CA-2541937-A1 (CA)
Inventor: GLENN BRADLEY J
IPC: A61F2/04
Filed: 2006-04-04
Abstract: Methods and devices are provided for shunting fluid to treat hydrocephalous, and in particular for treating normal pressure hydrocephalous, or Alzheimer's, Idiopathic Intracranial Hypertension (IIH), or any other condition in which it is necessary to drain and/or cleanse CSF. The methods and devices utilize a shunt having an inlet port, and outlet port, and a flow control component for controlling fluid flow from the inlet port to the outlet port. The shunt can be implanted at a location along or within a patient's spinal column. In one exemplary embodiment, an inlet port of a shunt can be implanted within the subarachnoid space, and an outlet port of a shunt can be implanted at a drainage site. In certain exemplary embodiments, the cerebrospinal fluid is drained into the epidural space.
Patent CA-2544346-A1 (CA)
Title: Fastening pin
Inventor: WESOLOWSKA MALGORZATA
IPC: F16B15/06
Filed: 2004-10-29
Abstract: A fastening pin (1) characterized by that it is equipped with elastic protrusions (2) preferably in the shape of convergent geometric figures, placed round the core, and with outer dimension of the protrusions (2) being greater than the hole dimension. The pin includes a joint (6) between an anchored part and a head (4) an being equipped with stabilizing fins (16). The pin (1) is especially suitable for fastening threshold-masking strips.
Patent CA-2546372-A1 (CA)
Title: Electrically conductive adhesive hydrogels with solubilizer
Inventor: BORDERS RICHARD ARNOLD
IPC: A61K47/40
Filed: 2004-09-08
Abstract: A composition providing electrically conductive adhesive hydrogels suitable for use as skin contact adhesives and, particularly, suitable for use as an electrical interface for disposable medical devices. The present hydrogels provide for reduced skin irritation and/or malodor properties, hydrate a subject's skin, readily wet around a subject's skin surface hair, and protect against burning of a subject upon or due to electrical stimulation through the hydrogel. These hydrogels generally include a monomer, a first initiator, a solubilizer, and a cross-linking agent. The present hydrogels also desirably include a buffer system to help prevent discoloration of the hydrogels and/or hydrolysis of the hydrogels as well as to improve shelf-life. Other additives such as conductivity enhancers, pharmaceuticals, humectants, plasticizers, skin health agents, etc. may be added to the present hydrogels either before or after curing.
Patent CA-2547754-A1 (CA)
Inventor: WOOD CLAUDIA
IPC: A61Q19/00
Filed: 2004-12-08
Abstract: The invention relates to copolymers containing, while being incorporated by polymerization, tert-butyl(meth)acrylate, at least one .alpha.,.szlig.-ethylenically unsaturated amide group-containing compound and acrylic acid.  The invention also relates to cosmetic and pharmaceutical agents containing at least one copolymer of the aforementioned type, and to the use of these copolymers.
Patent CA-2548656-A1 (CA)
Title: Infrared curing device having electrically actuated arm and system and method therewith
Inventor: VILLELLA SAM L
IPC: B25J9/02
Filed: 2006-05-26
Abstract: In certain embodiments, the present technique provides a system for curing a surface material disposed on a vehicle. The system includes an electrically actuated arm having an arm structure, a motorized drive coupled to the arm structure, and an actuator communicatively coupled to the motorized drive. The system also has a radiative curing device coupled to the arm structure, and a curing controller communicatively coupled to the radiative curing device.
Patent CA-2548687-A1 (CA)
Title: Luminaire reflector having attachment ring
Inventor: DUPRE SCOTT
IPC: F21V17/00
Filed: 2006-05-23
Abstract: A friction spring reflector assembly is described, the reflector attachment mechanism utilizing a push-on friction ring which acts alone or in combination as a mounting ring for mounting additional hardware such as a lens to a curved reflector cone without the use of adhesives or mounting bolts. The push-on friction ring maintains position through the use of a plurality of teeth which frictionally engage grooves or the smooth side wall of the reflector cone.
Patent CA-2549242-A1 (CA)
Title: Hydroxamic acid esters and pharmaceutical use thereof
Inventor: FENSHOLDT JEF
IPC: C07D213/38
Filed: 2004-12-02
Abstract: The invention relates to compounds of general formula I wherein D, E, F, G, W, Y R1, A, R9, X, B, R8 are as defined herein, and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use-alone or in combination with one or more other pharmaceutically active compounds- in therapy, for treating diseases associated with deregulated angiogeneseI, such as cancer
Patent CA-2551789-A1 (CA)
Title: Neutral endopeptidase (nep) and human soluble endopeptidase (hsep) inhibitors for prophylaxis and treatment of neurodegenerative disorders
Inventor: TURSKI LECHOSLAW A
IPC: A61K31/55
Filed: 2005-01-10
Abstract: The invention relates to a novel use of known benzazepine, benzoxazepine, benzothiazepine-N-acetic acid and phosphono-substituted benzazepinone derivatives having neutral endopeptidase (NEP) and/or human soluble endopeptidase (hSEP) inhibitory activity. The compounds of the invention are useful for the preparation of pharmaceutical compositions for prophylaxis an d treatment of neurodegenerative disorders. The compounds of the invention are known from the European patents EP 0 733 642 and EP 0 916 679, and can be described by the general formula (1) wherein the symbols have the meanings a s given above in the description.